Research location
Bridgeville
Pennsylvania, United States
Advertisement
Research activity in Bridgeville
Pennsylvania, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bridgeville
19 linked trials · page 1 of 1A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyNCT01436175 · 2012-02-27 · 1 site observation
TERMINATED
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive DisorderNCT01469377 · 2011-12-15 · 1 site observation
COMPLETED
Safety and Efficacy of Vilazodone in Major Depressive DisorderNCT01473381 · 2011-12-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderNCT01436149 · 2011-10-27 · 1 site observation
COMPLETED
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)NCT01360866 · 2011-10-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)NCT01360645 · 2011-07-01 · 1 site observation
COMPLETED
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderNCT01377194 · 2011-06-01 · 1 site observation
COMPLETED
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesNCT01336023 · 2011-05-23 · 1 site observation
COMPLETED
Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive DisorderNCT01085812 · 2010-03-01 · 1 site observation
COMPLETED
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderNCT00985725 · 2009-10-29 · 1 site observation
COMPLETED
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's DiseaseNCT00939783 · 2009-09-01 · 1 site observation
TERMINATED
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44NCT00948766 · 2009-07-01 · 1 site observation
COMPLETED
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseNCT00838110 · 2009-02-01 · 1 site observation
COMPLETED
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)NCT00644358 · 2007-12-31 · 1 site observation
COMPLETED
Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionNCT00591578 · 2007-12-01 · 1 site observation
COMPLETED
A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesNCT00467649 · 2007-05-01 · 1 site observation
COMPLETED
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 DiabetesNCT00229658 · 2005-09-01 · 1 site observation
COMPLETED
L-carnosine for SchizophreniaNCT00177177 · 2004-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.